Nexalin Technology
2 hedge funds and large institutions have $21K invested in Nexalin Technology in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.27% more ownership
Funds ownership: 0% → 0.27% (+0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.68K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $17K | +$21.2K | +15,481 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $4K | +$5.68K | +4,143 | New |
|
NXL Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q3 2022, worth a combined $21K.
Buyers outnumbered sellers: 2 funds opened new NXL positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.2K.
- 2 institutional investors held Nexalin Technology (NXL) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $21K of Nexalin Technology stock for Q3 2022.
- 2 funds opened new Nexalin Technology positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest Nexalin Technology buyer in Q3 2022 was Citadel Advisors, an estimated $21.2K added.
Based on aggregated 13F filings for Q3 2022.